Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 6.87
-0.36 (-4.98%)
Oct 23, 2026, 3:29 PM IST
Vaishali Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 41.65 | 8.17 | 7.19 | 66.04 | 40.24 |
Depreciation & Amortization | 5.96 | 4.82 | 5.03 | 5 | 4.56 |
Other Amortization | 0.04 | 0.05 | 0.05 | 0.04 | - |
Provision & Write-off of Bad Debts | 21.06 | 55.42 | 50.91 | - | - |
Other Operating Activities | 29.69 | 9.36 | -18.16 | 13.34 | 20.38 |
Change in Accounts Receivable | -64.01 | -25.14 | 0.56 | 48.95 | 82.25 |
Change in Inventory | 14.09 | -44.3 | 26.7 | -24.21 | -0.41 |
Change in Accounts Payable | -59.68 | 80.26 | -58.46 | -102.86 | -121.56 |
Change in Other Net Operating Assets | 15.56 | -269.02 | -5.76 | 4.49 | -12.28 |
Operating Cash Flow | 4.36 | -180.38 | 8.07 | 10.8 | 13.19 |
Operating Cash Flow Growth | - | - | -25.28% | -18.13% | -34.43% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -4.59 | -3.05 | -1.11 | -2.97 | -8.65 |
Investment in Securities | -51.3 | - | - | - | - |
Other Investing Activities | 1.29 | 1.17 | 13.14 | 5.79 | 0.18 |
Investing Cash Flow | -54.6 | -1.88 | 12.03 | 2.82 | -8.47 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 53.75 | - | 2.77 | - | 50.7 |
Long-Term Debt Issued | 14.95 | 5.97 | - | 22.53 | - |
Total Debt Issued | 68.7 | 5.97 | 2.77 | 22.53 | 50.7 |
Short-Term Debt Repaid | - | -15.47 | - | -67.57 | - |
Long-Term Debt Repaid | -3.21 | -3.19 | -15.21 | -2.8 | -21.08 |
Lease Payments | -3.21 | -3.19 | -1.91 | -2.8 | -2.26 |
Total Debt Repaid | -3.21 | -18.65 | -15.21 | -70.37 | -21.08 |
Net Debt Issued (Repaid) | 65.48 | -12.69 | -12.45 | -47.84 | 29.62 |
Other Financing Activities | -19.37 | 197.6 | -1.71 | 30.52 | -25.44 |
Financing Cash Flow | 46.12 | 184.91 | -14.16 | -17.32 | 4.18 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - |
Net Cash Flow | -4.13 | 2.65 | 5.94 | -3.71 | 8.89 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -0.23 | -183.43 | 6.96 | 7.82 | 4.54 |
Free Cash Flow Growth | - | - | -11.08% | 72.41% | -75.93% |
Free Cash Flow Margin | -0.02% | -18.52% | 0.81% | 1.12% | 0.60% |
Free Cash Flow Per Share | -0.00 | -1.45 | 0.07 | 0.07 | 0.04 |
Levered Free Cash Flow | -52.26 | -218.37 | -12.32 | -33.62 | -36.33 |
Unlevered Free Cash Flow | -40 | -208.47 | -1.46 | -19.51 | -20.78 |
Free Cash Flow After Leases | -3.45 | -186.61 | 5.05 | 5.03 | 2.27 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 19.37 | 14.97 | 17.38 | 18.89 | 24.4 |
Cash Income Tax Paid | 4.56 | 3.51 | 22.77 | 15.64 | 8.28 |
Change in Working Capital | -94.04 | -258.2 | -36.96 | -73.63 | -52 |